High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study (Q43892527)

From Wikidata

Jump to navigation Jump to search

scientific article published in February 2002

Language	Label	Description	Also known as
English	High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study	scientific article published in February 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Helicobacter pylori

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

author name string

Ulrich Peitz

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

M Sulliga

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

K Wolle

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

A Leodolter

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

U Von Arnim

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

S Kahl

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

M Stolte

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

G Börsch

8

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

J Labenz

9

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

P Malfertheiner

10

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

315-324

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01173.X

21 January 2018

Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01173.X

21 January 2018

A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01173.X

21 January 2018

Antibiotic resistance in Helicobacter pylori: implications for therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01173.X

21 January 2018

Treatment after failure: the problem of "non-responders".

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01173.X

21 January 2018

A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01173.X

21 January 2018

Prevalence of Helicobacter pylori resistance to several antimicrobial agents in a region of Germany

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01173.X

21 January 2018

The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: a meta-analysis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01173.X

21 January 2018

A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01173.X

21 January 2018

Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01173.X

21 January 2018

Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01173.X

21 January 2018

Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01173.X

21 January 2018

Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01173.X

21 January 2018

Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01173.X

21 January 2018

Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01173.X

21 January 2018

Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01173.X

21 January 2018

Treatment failures and secondary resistance to antibiotics. A growing concern in Helicobacter pylori therapy.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01173.X

21 January 2018

Regular review: treatment of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01173.X

21 January 2018

Identifiers

10.1046/J.1365-2036.2002.01173.X

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43892527&oldid=2104195812"